Hepatitis A in Adults: Experience from a Moroccan Hospital Center

Authors

  • Wafaa Hliwa Gastroenterology department, Ibn Rochd University Hospital, Casablanca, Morocco
  • Zineb Chraibi Gastroenterology department, Ibn Rochd University Hospital, Casablanca, Morocco
  • Hiba Ismail Gastroenterology department, Ibn Rochd University Hospital, Casablanca, Morocco
  • Fatema Ezzahra El Rhaoussi Gastroenterology department, Ibn Rochd University Hospital, Casablanca, Morocco
  • Mohamed Tahiri Gastroenterology department, Ibn Rochd University Hospital, Casablanca, Morocco
  • Fouad Haddad Gastroenterology department, Ibn Rochd University Hospital, Casablanca, Morocco
  • Ahmed Bellabah Gastroenterology department, Ibn Rochd University Hospital, Casablanca, Morocco
  • Wafaa Badre Gastroenterology department, Ibn Rochd University Hospital, Casablanca, Morocco

DOI:

https://doi.org/10.55677/IJCSMR/V4I3-07/2024

Keywords:

Hepatitis A virus - HAV - Adults – Jaundice - Vaccination

Abstract

Background: In children, hepatitis A virus infection is usually symptom-free and provides long-term immunity. However, in changing socio-economic environments, certain adults encounter infection risks, exposing them to symptomatic illness and complications. This study aims to outline the profile of adult hepatitis A patients.

Methods: We conducted a retrospective study from 2017 to 2023, involving all patients aged over 14 years who presented with acute hepatitis and tested positive for anti-HAV antibodies. Demographic, laboratory and clinical data were analyzed.

Results: The analysis involved 109 cases (mean age 21 +/- 6 years, 57.8% males). All patients were symptomatic. Among them, 71.6% presented with a pseudo-flu-like syndrome, 89% with jaundice, 50.5% with fever and 30.2% with gastrointestinal symptoms. Thirty patients were hospitalized (26.6%), among them one subfulminant was recorded. Clinically, hepatomegaly was found in 8 patients (7.3%). One patient had presented with a skin rash. Serum alanine aminotransferases levels were more than 50 times the normal range in 47.7% of cases, with an average bilirubin level of 89 mg/l. Severe acute hepatitis was observed in 26.6% of patients.

Conclusion: Our findings revealed that over 25% of adult patients experienced severe acute hepatitis, with one patient progressing to acute liver failure. These results underline the importance of raising awareness of hygiene practices and prompt a study of the overall seroprevalence of hepatitis in the adult population in order to improve viral hepatitis prevention and control strategies in the country.

References

Agrawal A, Singh S, Kolhapure S, Hoet B, Arankalle V, Mitra M. Increasing Burden of Hepatitis A in Adolescents and Adults and the Need for Long-Term Protection: A Review from the Indian Subcontinent. Infect Dis Ther. 2019 Dec;8(4):483-497. doi: 10.1007/s40121-019-00270-9. Epub 2019 Nov 2. PMID: 31679118; PMCID: PMC6856242.

Lai, Michelle, and Sanjiv Chopra. "Hepatitis A virus infection in adults: Epidemiology, clinical manifestations, and diagnosis." U: UpToDate, Baron EL ed. UpToDate [Internet]. Waltham, MA: UpToDate (2019).

Koroglu M, Jacobsen KH, Demiray T, Ozbek A, Erkorkmaz U, Altindis M. Socioeconomic indicators are strong predictors of hepatitis A seroprevalence rates in the Middle East and North Africa. J Infect Public Health. 2017 Sep-Oct;10(5):513-517. doi: 10.1016/j.jiph.2016.09.020. Epub 2017 Feb 2. PMID: 28162965.

Bouskraoui M, Bourrous M, Amine M. Prévalence des anticorps de l'hépatite A chez l'enfant dans la région de Marrakech [Prevalence of anti-hepatitis A virus antibodies in chidren in Marrakech]. Arch Pediatr. 2009 Oct;16 Suppl 2:S132-6. French. doi: 10.1016/S0929-693X(09)75317-5. PMID: 19836677.

WHO, Department of immunization, Vaccines and biological. The global prevalence of hepatitis A virus infection and susceptibility: a systematic review; 2010. Available from: http://www.whqlibdoc.who.int/hq/2010/ WHO_IVB_10.01_eng.pdf

Nandi B, Hadimani P, Arunachalam R, Ganjoo RK. Spectrum of acute viral hepatitis in Southern India. Medi J Armed Forces India. 2009;65(1):7–9.

Kamath SR, Sathiyasekaran M, Raja TE, Sudha L. Profile of viral hepatitis A in Chennai. Indian Pediatr. 2009;46(7):642–643.

Chadha MS, Lole KS, Bora MH, Arankalle VA. Outbreaks of hepatitis A among children in western India. Trans R Soc Trop Med Hyg. 2009;103(9):911–916.

Malik MJ, Shahid M, Naheed S, Alam AY, Khan EA. Are there reasons for universal immunization for hepatitis A virus infection? Rawal Med J. 2008;34(1):36–39.

Dahanayaka NJ, Kiyohara T, Agampodi SB, et al. Clinical features and transmission pattern of hepatitis A: an experience from a hepatitis a outbreak caused by two cocirculating genotypes in Sri Lanka. Am J Trop Med Hyg. 2016;95(4):908–914.

Hussain Z, Das BC, Husain SA, Murthy NS, Kar P. Increasing trend of acute hepatitis A in north India: need for identification of high-risk population for vaccination. J Gastroenterol Hepatol. 2006;21(4):689–693.

Ma, Michael MD1; Golfeyz, Shmuel MD2; Chen, Christine DO2; Naik, Jahnavi MD2. Relapsing Hepatitis A: An Asymptomatic Recurrence of Elevated Liver Chemistries: 2406. American Journal of Gastroenterology 113():p S1342-S1343, October 2018

Kassas AL, Telegdy L, Méhesfalvi E, Szilágyi T, Mihály I. Polyphasic and protracted patterns of hepatitis A infection: a retrospective study. Acta Med Hung. 1994;50(1-2):93.

Stránský J, Honzáková E, Vandasová J, Kyncl J. Relapsující a protrahovaná forma virové hepatitidy A: porovnání dospĕlých s dĕtmi [A relapsing and protracted form of viral hepatitis A: comparison of adults and children]. Vnitr Lek. 1995 Aug;41(8):525-30. Czech. PMID: 7483334.

Bhatt G, Sandhu VS, Mitchell CK. A rare presentation of hepatitis a infection with extrahepatic manifestations. Case Rep Gastrointest Med. 2014;2014:286914. doi: 10.1155/2014/286914. Epub 2014 Sep 14. PMID: 25295197; PMCID: PMC4177781.

Cao G, Jing W, Liu J, Liu M. The global trends and regional differences in incidence and mortality of hepatitis A from 1990 to 2019 and implications for its prevention. Hepatol Int. 2021 Oct;15(5):1068-1082. doi: 10.1007/s12072-021-10232-4. Epub 2021 Aug 3. PMID: 34345993; PMCID: PMC8514357.

Nelson NP, Weng MK, Hofmeister MG, Moore KL, Doshani M, Kamili S, Koneru A, Haber P, Hagan L, Romero JR, Schillie S, Harris AM. Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020. MMWR Recomm Rep. 2020 Jul 3;69(5):1-38. doi: 10.15585/mmwr.rr6905a1. Erratum in: MMWR Morb Mortal Wkly Rep. 2021 Feb 26;70(8):294. PMID: 32614811; PMCID: PMC8631741.

Downloads

Published

2024-03-27

How to Cite

Wafaa Hliwa, Zineb Chraibi, Hiba Ismail, Fatema Ezzahra El Rhaoussi, Mohamed Tahiri, Fouad Haddad, Ahmed Bellabah, & Wafaa Badre. (2024). Hepatitis A in Adults: Experience from a Moroccan Hospital Center. International Journal of Clinical Science and Medical Research, 4(3), 110–113. https://doi.org/10.55677/IJCSMR/V4I3-07/2024